SFL?s Managing Director to Speak at Life Science Network Basel Event
SFL is pleased to announce that Shayesteh Fürst-Ladani, Managing Director of the company, has been invited and will be giving a presentation entitled “Changing paradigms in regulatory requirements and regulatory affairs consultancy”at the upcoming Life Science Network Basel (LSNB) meeting on 20 June, 2012.
Shayesteh’s presentation at LSNB will provide insights into the latest regulatory developments impacting life science companies in both the Pharmaceutical and the Medical Devices areas. In addition, she will share her experience in founding and running a consulting company dedicated to the holistic support of life science companies in an increasingly complex regulatory and market environment. The success of her company led to it being awarded second prize in the Young Entrepreneurs Competition of Northwestern Switzerland in 2010.
LSNB is a non-profit organization that connects professionals and entrepreneurs working in the life science and healthcare industry in the Basel region of Switzerland. Basel and its surroundings are the home and working place of several thousand people working in the life sciences, pharmaceutical or biotechnology industry and associated sectors. Monthly LSNB events provide a platform for networking and information exchange.
“I am looking forward to speaking at LSNB about some of the new developments in the field of regulatory affairs that are affecting companies in the life sciences sector,” commented Shayesteh. “I hope that my presentation will encourage other entrepreneurs to consider setting up their own businesses in this area that thrives on innovation.”
Shayesteh is the Managing Director and founder of SFL Regulatory Affairs & Scientific Communication Ltd. She leads the team and provides global strategic support for the development of healthcare products. Shayesteh has a comprehensive knowledge base and experience in formulating global regulatory strategy for drugs, orphan drugs, drug & device combination products, borderline products, medical devices, in vitro diagnostics and advanced therapy medicinal products.
Shayesteh is Chair of Combination Products Topic Group at EuropaBio and Medical Device Working Group at EUCOPE. She has been member of the Program Committee of DIA EuroMeeting for 2011, 2012 and 2013 leading the Theme Drugs, Devices, In Vitro Diagnostics and their Combinations. Shayesteh is also Chair of SIAC (Special Interest Area Community) for Devices & Diagnostics at DIA.
About SFL Regulatory Affairs & Scientific Communication Ltd
SFL provides a holistic approach to lifecycle management of healthcare products. The company’s team of professionals have experience in Regulatory Affairs, Public Affairs, Legal Services and Medical Communications. We support our clients by offering personalized and comprehensive services. When combined, these services provide an integral oversight package for products from the bench to the marketplace at one consultancy.
For more information, please contact:
SFL Regulatory Affairs & Scientific Communication Ltd
Tel: +41 61 361 9443
Fax: +41 61 361 9442
Posted: June 2012